Baxter's Robert Parkinson - CEO Pay
Robert Parkinson - Baxter International
Total Compensation: $16M
Details: Parkinson received total compensation of $16 million, down form $17.6 million in 2007. According to SEC filings, Parkinson's compensation "reflects the role he plays in establishing Baxter's strategic agenda and long-range plan, meeting the challenges that arise in the day-to-day operations of a company as large and diverse as Baxter and leading the company in an increasingly challenging global economic environment."
The CEO's base salary came to $1.34 million, restricted stock awards totaled $5.54 million, options came to $5.3 million and cash compensation was $2.7 million. Perks leapt from $153,158 in 2007 to $212.326 in 2008.
Baxter News:
FDA finds 'final link' in heparin case
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: